QA: Viracta Therapeutics Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2017_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 43,231,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,000
3 remainder_Assets 0
4 LiabilitiesCurrent 10,939,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,255,496
9 ResearchAndDevelopmentExpense 22,572,834
10 remainder_Expenses 1,863,980
11 remainder_Revenues 2,637,386
12 remainder_NetIncome 1,391,437
13 remainder_ComprehensiveNetIncome -9,431
  yvar yval
0 Assets 43,234,000
1 Liabilities 10,939,000
2 Expenses 40,692,310
3 Revenues 2,637,386
4 StockholdersEquity 32,295,000
5 NetIncome -36,663,487
6 ComprehensiveNetIncome -36,668,202
7 BaseVar 49,451,782
8 EconomicCapitalRatiobeforeLimitedLiability 1.25
9 EconomicCapitalRatio 2.49

Edgar->Model Mapping

Feature Distribution

Change over Time